Your browser doesn't support javascript.
loading
LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
Wang, Yanliang; Feng, Yu Chen; Gan, Yujin; Teng, Liu; Wang, Li; La, Ting; Wang, Peilin; Gu, Yue; Yan, Lei; Li, Na; Zhang, Lina; Wang, Limeng; Thorne, Rick F; Zhang, Xu Dong; Cao, Huixia; Shao, Feng-Min.
Afiliação
  • Wang Y; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Feng YC; School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia.
  • Gan Y; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Teng L; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang L; Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Long Non-Coding RNA and Cancer Metabolism, Henan International Joint Laboratory of Non-Coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengz
  • La T; School of Basic Medicine Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
  • Wang P; Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Long Non-Coding RNA and Cancer Metabolism, Henan International Joint Laboratory of Non-Coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengz
  • Gu Y; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, Australia.
  • Yan L; Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Long Non-Coding RNA and Cancer Metabolism, Henan International Joint Laboratory of Non-Coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengz
  • Li N; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang L; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang L; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Thorne RF; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang XD; Department of Nephrology, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Cao H; Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Long Non-Coding RNA and Cancer Metabolism, Henan International Joint Laboratory of Non-Coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengz
  • Shao FM; Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Long Non-Coding RNA and Cancer Metabolism, Henan International Joint Laboratory of Non-Coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengz
J Exp Clin Cancer Res ; 41(1): 260, 2022 Aug 26.
Article em En | MEDLINE | ID: mdl-36028903
ABSTRACT

BACKGROUND:

Distant metastasis is the major cause of clear cell renal cell carcinoma (ccRCC)-associated mortality. However, molecular mechanisms involved in ccRCC metastasis remain to be fully understood. With the increasing appreciation of the role of long non-coding RNAs (lncRNAs) in cancer development, progression, and treatment resistance, the list of aberrantly expressed lncRNAs contributing to ccRCC pathogenesis is expanding rapidly.

METHODS:

Bioinformatics analysis was carried out to interrogate publicly available ccRCC datasets. In situ hybridization and qRT-PCR assays were used to test lncRNA expression in human ccRCC tissues and cell lines, respectively. Chromatin immunoprecipitation and luciferase reporter assays were used to examine transcriptional regulation of gene expression. Wound healing as well as transwell migration and invasion assays were employed to monitor ccRCC cell migration and invasion in vitro. ccRCC metastasis was also examined using mouse models in vivo. RNA pulldown and RNA immunoprecipitation were performed to test RNA-protein associations, whereas RNA-RNA interactions were tested using domain-specific chromatin isolation by RNA purification.

RESULTS:

MILIP expression was upregulated in metastatic compared with primary ccRCC tissues. The increased MILIP expression in metastatic ccRCC cells was driven by the transcription factor AP-2 gamma (TFAP2C). Knockdown of MILIP diminished the potential of ccRCC cell migration and invasion in vitro and reduced the formation of ccRCC metastatic lesions in vivo. The effect of MILIP on ccRCC cells was associated with alterations in the expression of epithelial-to-mesenchymal transition (EMT) hallmark genes. Mechanistically, MILIP formed an RNA-RNA duplex with the snail family transcriptional repressor 1 (Snai1) mRNA and bound to Y-box binding protein 1 (YBX1). This promoted the association between the YBX1 protein and the Snai1 mRNA, leading to increased translation of the latter. Snai1 in turn played an important role in MILIP-driven ccRCC metastasis.

CONCLUSIONS:

The TFAP2C-responsive lncRNA MILIP drives ccRCC metastasis. Targeting MILIP may thus represent a potential avenue for ccRCC treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Proteína 1 de Ligação a Y-Box / RNA Longo não Codificante / Fatores de Transcrição da Família Snail / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Proteína 1 de Ligação a Y-Box / RNA Longo não Codificante / Fatores de Transcrição da Família Snail / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article